Holen Sie sich die Stockscreener-App
2.14
0.93%
-0.02
Handel nachbörslich:
2.10
-0.04
-1.87%
Editas Medicine Inc Aktie (EDIT) Neueste Nachrichten
Is Editas Medicine Inc. stock in correction or buying zone2025 Growth vs Value & Reliable Entry Point Alerts - ulpravda.ru
Can Editas Medicine Inc. stock attract ESG capital inflowsWall Street Watch & Real-Time Buy Signal Notifications - ulpravda.ru
Will Editas Medicine Inc. stock remain a Wall Street favoriteMarket Sentiment Review & AI Driven Price Predictions - ulpravda.ru
Is Editas Medicine Inc. stock affected by interest rate hikesShort Setup & Reliable Volume Spike Trade Alerts - ulpravda.ru
Is Editas Medicine Inc. stock ready for breakout2025 Valuation Update & Free Expert Approved Momentum Trade Ideas - ulpravda.ru
Street Watch: Can Editas Medicine Inc. (8EM) stock expand revenue streams2025 Geopolitical Influence & Free Long-Term Investment Growth Plans - ulpravda.ru
Aug Catalysts: Why Editas Medicine Inc. (8EM) stock could rally stronglyQuarterly Profit Summary & Free Verified High Yield Trade Plans - ulpravda.ru
Gene Editing Tools Market to Reach US$ 1,700.05 million by 2033 | - openPR.com
Editas Medicine, Inc. (NASDAQ:EDIT) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Fibonacci Retracement Aligns with Support in Alka Securities LimitedMarket Sentiment Shifts & Free Realize Exceptional Returns - earlytimes.in
Editas Medicine (NASDAQ:EDIT) Stock Price Down 2.9%Should You Sell? - MarketBeat
Editas Medicine (EDIT) price target increased by 22.78% to 4.95 - MSN
Is Editas Medicine Inc. stock overvalued by current metricsGap Up & Reliable Trade Execution Plans - Улправда
Editas Medicine Stock Slides After-Hours On Bigger-Than-Expected Q4 Loss, But Retail Bulls Eye M&A Potential - MSN
Can Editas Medicine Inc. stock surprise with earnings upsideJuly 2025 Patterns & Fast Exit and Entry Trade Guides - Улправда
Editas Medicine Earnings Notes - Trefis
What margin trends mean for Editas Medicine Inc. stockIPO Watch & Weekly Chart Analysis and Guides - DonanımHaber
How Editas Medicine Inc. stock compares to growth peersPortfolio Profit Report & Precise Entry and Exit Recommendations - Bölüm Sonu Canavarı
Why Editas Medicine Inc. stock is seen as undervaluedOptions Play & Advanced Swing Trade Entry Alerts - DonanımHaber
Editas Medicine (LTS:0IFK) EV-to-FCF : -0.48 (As of Dec. 18, 2025) - GuruFocus
S P Trends: How Editas Medicine Inc stock compares to growth peersWeekly Profit Recap & Consistent Profit Trading Strategies - moha.gov.vn
Editas Medicine (FRA:8EM) EV-to-OCF : -0.45 (As of Dec. 18, 2025) - GuruFocus
Market Rankings: What margin trends mean for Editas Medicine Inc. stockIPO Watch & Capital Efficiency Focused Strategies - moha.gov.vn
Editas (EDIT) down 8.3% since last earnings report: Can it rebound? - MSN
What analysts say about Editas Medicine Inc stockTechnology Stock Trends & Small Budget Trading Plans - earlytimes.in
Editas (EDIT) Down 8.3% Since Last Earnings Report: Can It Rebound? - sharewise.com
Cell & Gene Therapy Market to Reach USD 105.83 Billion by 2033 - openPR.com
Editas Medicine, Inc. (NASDAQ:EDIT) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat
Editas Medicine (EDIT) Price Target Increased by 22.78% to 4.95 - Nasdaq
Editas Medicine (EDIT) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Editas Medicine (NASDAQ:EDIT) CEO Sells $12,046.45 in Stock - MarketBeat
Trend Recap: Is Editas Medicine Inc. (8EM) stock supported by free cash flowJuly 2025 Patterns & High Accuracy Swing Trade Signals - moha.gov.vn
What valuation ratios show for Editas Medicine Inc. (8EM) stockEarnings Summary Report & Reliable Intraday Trade Alerts - Newser
CEO O'Neill Surrenders 5,603 Of Editas Medicine Inc [EDIT] - TradingView
Editas Medicine CEO Sells Shares to Meet Tax Obligations - TradingView
How Editas Medicine Inc. (8EM) stock performs in easing cyclesJuly 2025 Selloffs & Safe Entry Momentum Tips - Newser
Editas Medicine (NASDAQ:EDIT) Shares Cross Below 50-Day Moving AverageTime to Sell? - MarketBeat
Will Editas Medicine Inc. (8EM) stock beat Nasdaq index returns2025 Pullback Review & Free Verified High Yield Trade Plans - Newser
Is Editas Medicine Inc. (8EM) stock positioned for digital growth eraMarket Growth Summary & Free Fast Gain Swing Trade Alerts - Newser
CEO O'Neill Files To Sell 7,000 Of Editas Medicine Inc [EDIT] - TradingView
Euro India Fresh Foods Limited Forms Bullish Flag Upside AheadCovered Call Writing & Learn From the Strategies of Institutions - earlytimes.in
FY2025 EPS Estimates for Editas Medicine Lowered by Analyst - MarketBeat
Editas Medicine (NASDAQ:EDIT) Stock Crosses Below 50-Day Moving AverageTime to Sell? - MarketBeat
Portfolio Shifts: Is Editas Medicine Inc. stock a bargain at current levelsMarket Activity Recap & Fast Moving Stock Trade Plans - moha.gov.vn
Editas (EDIT) Q2 2024 Earnings Call Transcript - The Globe and Mail
Editas Medicine Inc Stock Analysis and ForecastGeopolitical Risk Analysis & Access Free Risk Analysis Before You Invest - earlytimes.in
Editas Medicine (EDIT) Reports Q3 Loss, Beats Revenue Estimates - MSN
Editas Medicine price target raised to $4.60 from $4 at Clear Street - MSN
Is Editas Medicine Inc. (8EM) stock overpriced at current multiplesPortfolio Risk Report & Risk Controlled Swing Trade Alerts - newser.com
Is Editas Medicine Inc. (8EM) stock in buy zone after pullbackJuly 2025 Rallies & AI Powered Market Entry Strategies - newser.com
Will Editas Medicine Inc. (8EM) stock gain from green policies2025 Big Picture & Technical Confirmation Alerts - newser.com
0.80%
4.56%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):